Biomarkers Indicating Increased Mortality Risk in the Elderly
Written on
Understanding Aging and Cellular Senescence
Aging is a pervasive process that affects our entire body. As cells age, they may enter a state known as senescence, where they cease to divide and start exhibiting the senescence-associated secretory phenotype (SASP). This phenomenon leads to the release of harmful molecules that can damage neighboring cells, including inflammatory substances and protein-degrading enzymes. Consequently, the aging process can propagate from one cell to another.
Current strategies to combat aging often involve either inhibiting SASP or eliminating senescent cells using a class of compounds called senolytics. However, identifying the precise targets for these senolytics—essentially, the indicators that help them locate and eliminate senescent cells—remains a challenge, and researchers are actively investigating various possibilities.
An alternative approach is to prevent cells from reaching the SASP stage altogether, potentially through the application of stem cells that may rejuvenate aging tissues. Another intriguing question is whether we can reprogram our cells entirely.
Emerging biomarkers may provide insights into the extent of cellular senescence or the overall aging process within our bodies. Certain specific markers released by senescent cells into the bloodstream are linked to advanced biological age and various health issues, such as frailty and diminished physical function.
However, a pressing question arises: Do we really need all these molecular markers, or are there some that are particularly indicative of imminent health risks?
Investigating the Key Biomarkers
To explore the relationship between senescence markers and health outcomes, a recent study examined 1,923 older adults (aged 65 and above) from the Mayo Clinic Biobank, all of whom had either no chronic health conditions or only one. Participants were monitored for an average of 6.3 years, during which 283 individuals passed away, predominantly from cancer, heart disease, and dementia.
The study confirmed some straightforward observations: older age and male gender correlated with a heightened risk of mortality. Interestingly, participants with one chronic condition at the outset exhibited a lower mortality rate during the follow-up compared to those without any chronic conditions, potentially due to regular medical check-ups.
Focusing on the Critical Biomarkers
Researchers assessed 28 potential biomarkers of cellular senescence in blood samples from participants. They found that 23 of these markers correlated with chronological age, with some demonstrating stronger associations than others. Notably, the levels of these biomarkers varied between men and women.
The five most significant markers associated with increased mortality risk were: GDF15, RAGE, VEGFA, PARC, and MMP2. These markers remained strongly linked to mortality risk even after accounting for age, sex, race, and existing health conditions.
- GDF15: High levels of this protein, which is involved in inflammation and programmed cell death, significantly increased the risk of mortality, nearly doubling it.
- RAGE: Surprisingly, low levels of RAGE, which usually acts as a receptor for pro-inflammatory substances, were linked to heightened mortality risk. While high RAGE levels are detrimental for individuals with chronic illnesses, lower levels may indicate a lack of protection in healthier individuals. Notably, women had higher levels of TNFR1, which is associated with inflammation.
- VEGFA: Ranking third, this growth factor is essential for new blood vessel formation but can indicate inflammation or tumor activity when present in high concentrations.
- PARC: This signaling protein activates the immune response, potentially prolonging inflammation.
- MMP2: This enzyme breaks down extracellular matrix components, crucial for tissue remodeling. However, excessive levels can lead to complications, including respiratory issues and an environment conducive to cancer cell invasion.
It's important to recognize that this study primarily focused on a relatively homogeneous group, which may limit the applicability of the findings. Additionally, this population was generally healthier than the average older demographic, potentially skewing the results.
A key takeaway is that four out of the five biomarkers linked to increased mortality risk are indicative of chronic inflammation.
In conclusion, the study suggests that biomarkers related to cellular senescence enhance the prediction of mortality beyond traditional demographic and clinical factors, indicating that the concentration of these proteins may reflect fundamental aging mechanisms that ultimately lead to death. This underlying mechanism could very well be chronic inflammation, often referred to as "inflammaging."
In the first video, "Ceramides as a New Biomarker For Cardiovascular Risk Prediction," experts discuss how ceramides may serve as valuable indicators for assessing cardiovascular risk in patients.
The second video, "The Use of Biomarkers in the ED to Aid in Assessing High-Risk Patients," examines the role of various biomarkers in emergency departments for evaluating patients at high risk for adverse outcomes.